Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany- A Population-Based Modelling Study
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1147
https://www.valueinhealthjournal.com/article/S1098-3015(17)31481-X/fulltext
Title :
Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany- A Population-Based Modelling Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31481-X&doi=10.1016/j.jval.2017.08.1147
First page :
A600
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1095